What is PHOE's health score?

Phoenix Asia Holdings Ltd (PHOE) has a TradeApes health score of 69 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is PHOE's estimated fair value?

Based on our 5-year discounted cash flow model, Phoenix Asia Holdings Ltd's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is PHOE undervalued or overvalued?

Our model currently rates PHOE as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

Create an account for unlimited access

Phoenix Asia Holdings Ltd (PHOE)

Industrials Inconclusive inconclusive healthy

$31.32

Updated: 2026-07-18

TradeApes Score

Financial Strength

90 Strong

Operating Trend

85 Strong

Relative Value

50 Mixed

Capital Allocation

30 Weak

Risk Management

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

Industry Related Stocks

American Airlines Group Inc. (AAL) Absci Corp (ABSI) Arcosa, Inc. (ACA) Acco Group Holdings Ltd (ACCL) ACCESS Newswire Inc. (ACCS) ACORN ENERGY, INC. (ACFN)

See all Industrials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.